Found: 28
Select item for more details and to access through your institution.
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E557, doi. 10.1002/ajh.24817
- By:
- Publication type:
- Article
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67906-w
- By:
- Publication type:
- Article
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 207, doi. 10.3390/cancers14010207
- By:
- Publication type:
- Article
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 188, doi. 10.3390/cancers14010188
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET in malignant lymphoma: significance of positive findings.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 7, p. 749, doi. 10.1007/s00259-004-1748-x
- By:
- Publication type:
- Article
Lenalidomide in Pretreated Patients with Diffuse Large B‐Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1246, doi. 10.1634/theoncologist.2018-0603
- By:
- Publication type:
- Article
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1033, doi. 10.1634/theoncologist.2017-0597
- By:
- Publication type:
- Article
ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S392, doi. 10.1016/S2152-2650(21)01890-5
- By:
- Publication type:
- Article
Poster: ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01496-8
- By:
- Publication type:
- Article
Characterization of Duvelisib in Patients with Refractory Marginal Zone Lymphoma: Data from the Phase 2 DYNAMO Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S312, doi. 10.1016/j.clml.2019.07.283
- By:
- Publication type:
- Article
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Lenalidomide in Combination with Dexamethasone in Elderly Patients with Advanced, Relapsed or Refractory Multiple Myeloma and Renal Failure.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2013, v. 5, n. 1, p. 1, doi. 10.4084/MJHID.2013.037
- By:
- Publication type:
- Article
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Gemcitabine as frontline treatment for cutaneous T‐cell lymphoma: Phase II study of 32 patients.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 11, p. 2437
- By:
- Publication type:
- Article
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 10, p. 2190
- By:
- Publication type:
- Article
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Early relapse in a patient with Hodgkin’s disease and negative interim FDG-PET.
- Published in:
- Annals of Nuclear Medicine, 2008, v. 22, n. 5, p. 429, doi. 10.1007/s12149-008-0105-8
- By:
- Publication type:
- Article
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Bronchus-Associated Lymphoid Tissue Lymphomas: An Update of a Rare Extranodal Maltoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 9, p. 566
- By:
- Publication type:
- Article
Predictive Role of Positron Emission Tomography in the Outcome of Patients with Follicular Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 4, p. 291
- By:
- Publication type:
- Article
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 947, doi. 10.1002/hon.3211
- By:
- Publication type:
- Article
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.789891
- By:
- Publication type:
- Article
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0590-1
- By:
- Publication type:
- Article
SEQUOIA: results of a phase 3 randomized study of Zanubrutinib versus Bendamustine + Rituximab (BR) in patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 32
- By:
- Publication type:
- Article